About Alveus Therapeutics
Alveus Therapeutics is a private company based in Philadelphia, Pennsylvania, incorporated in 2023 in Delaware. It has reported $56,862,480 raised in one offering on Form D since January 2026. Its chief executive is Raj Kannan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 22, 2025 | Jan 14, 2026 | $56,862,480of $110.7M target | 17 | $3.3M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alveus Therapeutics's Form D filed Jan 14, 2026.
CN
Claudio Nessi
Director
AN
Ameet Nathwani
Director
IG
Ivan Gergel
Director
JB
Jan Van de Bossche
Director
CN
Carlo de Notaristefani
Director
GI
Garrett Ingram
Director
RK
Raj Kannan
Chief Executive Officer and director
GP
Gregory Parekh
Director